Immunopathogenesis of hantavirus pulmonary syndrome and hemorrhagic fever with renal syndrome: Do CD8+ T cells trigger capillary leakage in viral hemorrhagic fevers?

Immunology Letters

Volumn 113, Issue 2, 2007, Pages 117-120

  Terajima, Masanori ^a   Hayasaka, Daisuke ^a   Maeda, Ken ^a   Ennis, Francis A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Cytotoxic T lymphocytes; Endothelial cells; Hantavirus; Hantavirus pulmonary syndrome; Hemorrhagic fever with renal syndrome; PD 1; PD L1; PD L2

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

CAPILLARY LEAK SYNDROME; CD8+ T LYMPHOCYTE; CRUSH SYNDROME; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; ENDOTHELIUM CELL; GENE SEQUENCE; HANTAVIRUS; HANTAVIRUS PULMONARY SYNDROME; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; LETTER; MARBURG VIRUS; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RNA SEQUENCE; SYMPTOMATOLOGY; VIRUS HEMORRHAGIC FEVER;

ANIMALS; CAPILLARY PERMEABILITY; CD8-POSITIVE T-LYMPHOCYTES; ENDOTHELIAL CELLS; HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMANS; MICE;

EID: 35248869184     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2007.08.003     Document Type: Letter

References (56)

1. Peters C.J. Viral hemorrhagic fevers. In: Nathanson N. (Ed). Viral pathogenesis (1997), Lippincott-Raven, Philadelphia 779-799
2. Peters C.J., and Zaki S.R. Role of the endothelium in viral hemorrhagic fevers. Crit Care Med 30 (2002) S268-S273
3. Schnittler H.J., Mahner F., Drenckhahn D., Klenk H.D., and Feldmann H. Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. J Clin Invest 91 (1993) 1301-1309
4. Yanagihara R., and Silverman D.J. Experimental infection of human vascular endothelial cells by pathogenic and nonpathogenic hantaviruses. Arch Virol 111 (1990) 281-286
5. Pensiero M.N., Sharefkin J.B., Dieffenbach C.W., and Hay J. Hantaan virus infection of human endothelial cells. J Virol 66 (1992) 5929-5936
6. Khaiboullina S.F., Netski D.M., Krumpe P., and St Jeor S.C. Effects of tumor necrosis factor alpha on Sin Nombre virus infection in vitro. J Virol 74 (2000) 11966-11971
7. Sundstrom J.B., McMullan L.K., Spiropoulou C.F., Hooper W.C., Ansari A.A., Peters C.J., et al. Hantavirus infection induces the expression of RANTES and IP-10 without causing increased permeability in human lung microvascular endothelial cells. J Virol 75 (2001) 6070-6085
8. Schmaljohn C.S., and Hooper J.W. Bunyaviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields virology (2001), Lippincott Williams & Wilkins, Philadelphia 1581-1602
9. Nichol S.T. Bunyaviruses. In: Knipe D.M., and Howley P.M. (Eds). Fields virology (2001), Lippincott Williams & Wilkins, Philadelphia 1603-1633
10. Plyusnin A. Genetics of hantaviruses: implications to taxonomy. Arch Virol 147 (2002) 665-682
11. Schmaljohn C., and Hjelle B. Hantaviruses: a global disease problem. Emerg Infect Dis 3 (1997) 95-104
12. Peters C.J., Simpson G.L., and Levy H. Spectrum of hantavirus infection: hemorrhagic fever with renal syndrome and hantavirus pulmonary syndrome. Annu Rev Med 50 (1999) 531-545
13. Khan A.S., and Young J.C. Hantavirus pulmonary syndrome: at the crossroads. Curr Opin Infect Dis 14 (2001) 205-209
14. Peters C.J., and Khan A.S. Hantavirus pulmonary syndrome: the new American hemorrhagic fever. Clin Infect Dis 34 (2002) 1224-1231
15. Koster F.T., and Jenison S.A. Hantaviruses. In: Gorbach S.L., Bartlett J.G., and Blacklow N.R. (Eds). Infectious diseases (1997), WB Saunders, Philadelphia
16. Zaki S.R., Greer P.W., Coffield L.M., Goldsmith C.S., Nolte K.B., Foucar K., et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol 146 (1995) 552-579
17. Nolte K.B., Feddersen R.M., Foucar K., Zaki S.R., Koster F.T., Madar D., et al. Hantavirus pulmonary syndrome in the United States: a pathological description of a disease caused by a new agent. Hum Pathol 26 (1995) 110-120
18. Kang J.I., Park S.H., Lee P.W., and Ahn B.Y. Apoptosis is induced by hantaviruses in cultured cells. Virology 264 (1999) 99-105
19. Li X.D., Kukkonen S., Vapalahti O., Plyusnin A., Lankinen H., and Vaheri A. Tula hantavirus infection of Vero E6 cells induces apoptosis involving caspase 8 activation. J Gen Virol 85 (2004) 3261-3268
20. Li X.D., Lankinen H., Putkuri N., Vapalahti O., and Vaheri A. Tula hantavirus triggers pro-apoptotic signals of ER stress in Vero E6 cells. Virology 333 (2005) 180-189
21. Markotic A., Hensley L., Geisbert T., Spik K., and Schmaljohn C. Hantaviruses induce cytopathic effects and apoptosis in continuous human embryonic kidney cells. J Gen Virol 84 (2003) 2197-2202
22. Gavrilovskaya I.N., Shepley M., Shaw R., Ginsberg M.H., and Mackow E.R. Beta3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc Natl Acad Sci USA 95 (1998) 7074-7079
23. Gavrilovskaya I.N., Brown E.J., Ginsberg M.H., and Mackow E.R. Cellular entry of hantaviruses which cause hemorrhagic fever with renal syndrome is mediated by beta3 integrins. J Virol 73 (1999) 3951-3959
24. Tsukada H., Ying X., Fu C., Ishikawa S., McKeown-Longo P., Albelda S., et al. Ligation of endothelial alpha v beta 3 integrin increases capillary hydraulic conductivity of rat lung. Circ Res 77 (1995) 651-659
25. Niikura M., Maeda A., Ikegami T., Saijo M., Kurane I., and Morikawa S. Modification of endothelial cell functions by Hantaan virus infection: prolonged hyper-permeability induced by TNF-alpha of hantaan virus-infected endothelial cell monolayers. Arch Virol 149 (2004) 1279-1292
26. Gavrilovskaya I.N., Peresleni T., Geimonen E., and Mackow E.R. Pathogenic hantaviruses selectively inhibit beta3 integrin directed endothelial cell migration. Arch Virol 147 (2002) 1913-1931
27. Ennis F.A., Cruz J., Spiropoulou C.F., Waite D., Peters C.J., Nichol S.T., et al. Hantavirus pulmonary syndrome: CD8+ and CD4+ cytotoxic T lymphocytes to epitopes on Sin Nombre virus nucleocapsid protein isolated during acute illness. Virology 238 (1997) 380-390
28. Terajima M., Vapalahti O., Van Epps H.L., Vaheri A., and Ennis F.A. Immune responses to Puumala virus infection and the pathogenesis of nephropathia epidemica. Microbes Infect 6 (2004) 238-245
29. Kilpatrick E.D., Terajima M., Koster F.T., Catalina M.D., Cruz J., and Ennis F.A. Role of specific CD8+ T cells in the severity of a fulminant zoonotic viral hemorrhagic fever, hantavirus pulmonary syndrome. J Immunol 172 (2004) 3297-3304
30. Khaiboullina S.F., and St Jeor S.C. Hantavirus immunology. Viral Immunol 15 (2002) 609-625
31. Maes P., Clement J., Gavrilovskaya I., and Van Ranst M. Hantaviruses: immunology, treatment, and prevention. Viral Immunol 17 (2004) 481-497
32. Borges A.A., Campos G.M., Moreli M.L., Souza R.L., Aquino V.H., Saggioro F.P., et al. Hantavirus cardiopulmonary syndrome: immune response and pathogenesis. Microbes Infect 8 (2006) 2324-2330
33. Mori M., Rothman A.L., Kurane I., Montoya J.M., Nolte K.B., Norman J.E., et al. High levels of cytokine-producing cells in the lung tissues of patients with fatal hantavirus pulmonary syndrome. J Infect Dis 179 (1999) 295-302
34. Koster F., Vigil J., Olson D., Terajima M., Ennis F., Moehenkamp C., et al. Class I, II and III HLA alleles associated with severe hantavirus cardiopulmonary syndrome in the southwest US (meeting abstract). Am J Trop Med 65 (2001) 152
35. Hayasaka D., Maeda K., Ennis F.A., and Terajima M. Increased permeability of human endothelial cell line EA.hy926 induced by hantavirus-specific cytotoxic T lymphocytes. Virus Res 123 (2007) 120-127
36. Mustonen J., Partanen J., Kanerva M., Pietila K., Vapalahti O., Pasternack A., et al. Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int 49 (1996) 217-221
37. Makela S., Mustonen J., Ala-Houhala I., Hurme M., Partanen J., Vapalahti O., et al. Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism. J Infect Dis 186 (2002) 843-846
38. Mustonen J., Partanen J., Kanerva M., Pietila K., Vapalahti O., Pasternack A., et al. Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol 47 (1998) 277-279
39. Temonen M., Mustonen J., Helin H., Pasternack A., Vaheri A., and Holthofer H. Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol 78 (1996) 47-55
40. Linderholm M., Ahlm C., Settergren B., Waage A., and Tarnvik A. Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis 173 (1996) 38-43
41. Makela S., Mustonen J., Ala-Houhala I., Hurme M., Koivisto A.M., Vaheri A., et al. Urinary excretion of interleukin-6 correlates with proteinuria in acute Puumala hantavirus-induced nephritis. Am J Kidney Dis 43 (2004) 809-816
42. Araki K., Yoshimatsu K., Lee B.H., Kariwa H., Takashima I., and Arikawa J. Hantavirus-specific CD8(+)-T-cell responses in newborn mice persistently infected with Hantaan virus. J Virol 77 (2003) 8408-8417
43. Araki K., Yoshimatsu K., Lee B.H., Kariwa H., Takashima I., and Arikawa J. A new model of Hantaan virus persistence in mice: the balance between HTNV infection and CD8(+) T-cell responses. Virology 322 (2004) 318-327
44. Araki K., Yoshimatsu K., Lee B.H., Okumura M., Kariwa H., Takashima I., et al. Age-dependent hantavirus-specific CD8(+) T-cell responses in mice infected with Hantaan virus. Arch Virol 149 (2004) 1373-1382
45. Mestas J., and Hughes C.C. Of mice and not men: differences between mouse and human immunology. J Immunol 172 (2004) 2731-2738
46. Zhao M.Q., Stoler M.H., Liu A.N., Wei B., Soguero C., Hahn Y.S., et al. Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition. J Clin Invest 106 (2000) R49-R58
47. Xu L., Yoon H., Zhao M.Q., Liu J., Ramana C.V., and Enelow R.I. Cutting edge: pulmonary immunopathology mediated by antigen-specific expression of TNF-alpha by antiviral CD8+ T cells. J Immunol 173 (2004) 721-725
48. Rothermel A.L., Wang Y., Schechner J., Mook-Kanamori B., Aird W.C., Pober J.S., et al. Endothelial cells present antigens in vivo. BMC Immunol 5 (2004) 5
49. Johnson D.R. Endothelial cell-mediated antigen presentation. Transfus Med Hemother 33 (2006) 58-70
50. Rodig N., Ryan T., Allen J.A., Pang H., Grabie N., Chernova T., et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol 33 (2003) 3117-3126
51. Mazanet M.M., and Hughes C.C. B7-H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J Immunol 169 (2002) 3581-3588
52. Eppihimer M.J., Gunn J., Freeman G.J., Greenfield E.A., Chernova T., Erickson J., et al. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation 9 (2002) 133-145
53. Alff P.J., Gavrilovskaya I.N., Gorbunova E., Endriss K., Chong Y., Geimonen E., et al. The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses. J Virol 80 (2006) 9676-9686
54. Spiropoulou C.F., Albarino C.G., Ksiazek T.G., and Rollin P.E. Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J Virol 81 (2007) 2769-2776
55. Salazar G., Colombo G., Lenna S., Antonioli R., Beretta L., Santaniello A., et al. HLA-B35 influences the apoptosis rate in human peripheral blood mononucleated cells and HLA-transfected cells. Hum Immunol 68 (2007) 181-191
56. Rothman A.L., and Ennis F.A. Immunopathogenesis of Dengue hemorrhagic fever. Virology 257 (1999) 1-6